We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$21.5B
1-Year Est. Return
81.81%
This Fund
S&P 500
This Quarter
Est. Return
+6.75%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
–
AUM
$5.18B
AUM Growth
-$1.23B
(-19%)
Cap. Flow
-$121M
Cap. Flow
% of AUM
-2.34%
Top 10 Holdings %
Top 10 Hldgs %
16.5%
Holding
1,730
New
499
Increased
190
Reduced
247
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$12.3M |
| 2 |
KraneShares CSI China Internet ETF
KWEB
|
+$11.1M |
| 3 |
WWE
World Wrestling Entertainment
WWE
|
+$10.5M |
| 4 |
Walt Disney
DIS
|
+$10.3M |
| 5 |
UBS Group
UBS
|
+$10M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PMT
PennyMac Mortgage Investment
PMT
|
+$17.9M |
| 2 |
Antero Resources
AR
|
+$17.5M |
| 3 |
Teck Resources
TECK
|
+$17.2M |
| 4 |
ONC
BeOne Medicines Ltd
ONC
|
+$16.4M |
| 5 |
EQT Corp
EQT
|
+$14.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.4% |
| 2 | Healthcare | 2.04% |
| 3 | Technology | 1.38% |
| 4 | Consumer Discretionary | 0.99% |
| 5 | Communication Services | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSVT
876
CALL
DELISTED
2seventy bio
TSVT
| $306K | 0.01% |
+30,000
| New | +$343K |
|
|
TSVT
877
PUT
DELISTED
2seventy bio
TSVT
| $306K | 0.01% |
+30,000
| New | +$343K |
|
878
PUT
Arbutus Biopharma
ABUS
$1B
| $303K | 0.01% |
100,000
| – | – |
|
879
Spotify
SPOT
$113B
| $301K | 0.01% |
+2,250
| New | +$258K |
|
880
Community Health Systems
CYH
$420M
| $297K | 0.01% |
60,600
-557,788
| -90% | -$2.94M |
|
881
Cannae Holdings
CNNE
$658M
| $293K | 0.01% |
14,500
| – | – |
|
882
Sigma Lithium
SGML
$1.01B
| $292K | 0.01% |
+7,769
| New | +$249K |
|
|
FORG
883
DELISTED
ForgeRock, Inc.
FORG
| $288K | 0.01% |
+14,000
| New | +$284K |
|
884
Sarepta Therapeutics
SRPT
$2.09B
| $287K | 0.01% |
+2,079
| New | +$270K |
|
|
AKTS
885
DELISTED
Akoustis Technologies Inc
AKTS
| $285K | 0.01% |
+92,600
| New | +$323K |
|
886
Itron
ITRI
$4.03B
| $277K | 0.01% |
+5,000
| New | +$276K |
|
887
CALL
Coherus Oncology
CHRS
$188M
| $274K | 0.01% |
40,000
| – | – |
|
|
888
PUT
Coherus Oncology
CHRS
$188M
| $274K | 0.01% |
40,000
| – | – |
|
889
Citizens Financial Group
CFG
$28.2B
| $273K | 0.01% |
+9,000
| New | +$352K |
|
890
CALL
Immunovant
IMVT
$7.51B
| $271K | 0.01% |
+17,500
| New | +$304K |
|
|
891
PUT
Immunovant
IMVT
$7.51B
| $271K | 0.01% |
+17,500
| New | +$304K |
|
892
CALL
Aclaris Therapeutics
ACRS
$783M
| $269K | 0.01% |
+33,200
| New | +$421K |
|
893
MillerKnoll
MLKN
$1.44B
| $266K | 0.01% |
+13,000
| New | +$292K |
|
894
PUT
B&G Foods
BGS
$255M
| $266K | 0.01% |
17,100
-52,900
| -76% | -$737K |
|
895
CALL
Revolve Group
RVLV
$1.47B
| $263K | 0.01% |
+10,000
| New | +$258K |
|
896
Arrowhead Research
ARWR
$9.29B
| $262K | 0.01% |
+10,300
| New | +$324K |
|
897
CALL
Banco Macro
BMA
$4.87B
| $256K | 0.01% |
+14,400
| New | +$286K |
|
898
Titan Machinery
TITN
$559M
| $256K | ﹤0.01% |
+8,400
| New | +$342K |
|
899
Buckle
BKE
$2.06B
| $245K | ﹤0.01% |
+6,875
| New | +$282K |
|
|
BTAI
900
DELISTED
BioXcel Therapeutics
BTAI
| $243K | ﹤0.01% |
+813
| New | +$347K |
|
Similar funds
AWM
LCIP
BPA
SA
AA
RAM
FCM
BG
Caption Management's Q1 2023 Portfolio in Review
As of Q1 2023, Caption Management held 1,730 positions worth $5.18B, down 19% from $6.41B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Caption Management's Q1 2023 filing shows 499 new, 190 increased, 247 reduced and 699 closed positions. Its largest new stake was World Wrestling Entertainment: 123,000 shares worth $11.2M. The largest sale was PennyMac Mortgage Investment, an estimated $17.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, up from 91% a quarter earlier, followed by Healthcare and Technology.
- Caption Management's largest Q1 2023 buy was World Wrestling Entertainment: 123,000 shares worth $11.2M.
- Caption Management added most to Madrigal Pharmaceuticals in Q1 2023, an estimated $12.3M increase.
- Caption Management's biggest Q1 2023 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $13.3M.
- Caption Management fully exited PennyMac Mortgage Investment in Q1 2023, selling an estimated $17.9M.
- Caption Management's ten largest holdings make up 16% of its $5.18B portfolio in Q1 2023.
- Caption Management opened 499 new positions and closed 699 in Q1 2023.
- Caption Management's portfolio value fell 19% quarter-over-quarter to $5.18B.
Based on Caption Management's 13F filing for Q1 2023, filed 15 May 2023.